Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Clinical Nuclear Medicine|March 7, 2025
TANDEM Peptide Receptor Radionuclide Therapy Using [225Ac]Ac-/[177Lu]Lu-DOTA-LM3 in a Patient With Parotid Gland Metastasis From Pancreatic Neuroendocrine NeoplasmElisabetta Perrone, Kriti Ghai, Aleksandr Eismant, et al.Clinical Nuclear Medicine|June 29, 2023
Synchronous Treatment of Breast Cancer Hepatic Metastases by Transarterial Radioembolization and Radiofrequency Thermoablation: A Case ReportElisabetta Perrone, Roberto Moretti, Luca Indovina, et al.Clinical Nuclear Medicine|February 25, 2025
Axillary Skin Fibroblast Activation Protein Uptake After Chemo-immunotherapy on PET/CT and SPET/CT: A Mere Coincidence or Causality?Elisabetta Perrone, Kriti Ghai, Aleksandr Eismant, et al.Clinical Nuclear Medicine|August 3, 2026
Recurrent Metastatic Esthesioneuroblastoma: First-in-human α/β PRRT With Actinium-225/Lutetium-177-DOTA-LM3 SSTR Antagonist Achieving Partial Response After Failure of Lutetium-177-DOTATOC PRRTElisabetta Perrone, Kriti Ghai, Aleksandr Eismant, et al.The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|September 6, 2022
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosusAndrea Guarneri, Elisabetta Perrone, Silvia L Bosello, et al.Clinical Nuclear Medicine|April 1, 2026
First-in-Human Combination of Lead-212-Labeled PSMA Radioligand Therapy and Metabotropic Glutamate Receptor Inhibitor Riluzole as Radiosensitizer in Metastatic Castration-resistant Prostate CancerElisabetta Perrone, Lukas Greifenstein, Kriti Ghai, et al.Cancers|February 11, 2023
PET/CT with Fibroblast Activation Protein Inhibitors in Breast Cancer: Diagnostic and Theranostic Application-A Literature ReviewSilvia Taralli, Margherita Lorusso, Elisabetta Perrone, et al.International Journal of Molecular Sciences|July 29, 2025
In Vivo Versus In Vitro Somatostatin Receptor Expression in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis of Correlation StudiesElisabetta Perrone, Giorgio Treglia, Romina Grazia Giancipoli, et al.Clinical Nuclear Medicine|November 27, 2025
First Autopsy-confirmed Complete Remission of Metastatic Neuroendocrine Neoplasm of Tailgut Cyst After a Single Cycle of Alpha-Peptide Receptor Radionuclide Therapy With [225Ac]Ac-DOTA-LM3Elisabetta Perrone, Shagufta Shaheen, Pamela L Kunz, et al.Anticancer Research|April 27, 2024
Breast Relapse of Pediatric B-Cell Acute Lymphoblastic Leukemia After CAR-T Therapy Detected by 18F-FDG PET/CTElisabetta Perrone, Silvia Taralli, Daria Pagliara, et al.Pageof 4